Randomized Clinical Trial
Copyright ©The Author(s) 2024.
World J Psychiatry. Sep 19, 2024; 14(9): 1375-1385
Published online Sep 19, 2024. doi: 10.5498/wjp.v14.i9.1375
Table 1 Demographic data, Hamilton Depression Rating Scale score, Zung’s Self-rating Depression Scale score, Montreal Cognitive Assessment score, and cardiorespiratory findings of three groups of patients
CharacteristicsGroup 1: qCON 60-70
Group 2: qCON 50-60
Group 3: qCON40-50
Age, years32.3 ± 14.233.9 ± 15.031.9 ± 13.6
Male2/81/81/8
Weight, kg55.6 ± 7.055.9 ± 13.657.8 ± 15.5
Height, cm162.3 ± 9.1162.1 ± 9.9164.9 ± 5.9
Propofol dose, mg (IQR)85.5 (72.0, 88.5)87.0 (70.5, 100.5)85.5 (66.0, 105.0)
Succinylcholine dose, mg (IQR)57.0 (48.0, 59.0)58.0 (47.0, 67.0)57.0 (44.0, 70.0)
Interventions, median (IQR)8 (7, 9)8 (6.5, 10)8 (7.5, 8)
Baseline HAMD-24 score42.8 ± 4.441.3 ± 4.442.3 ± 4.0
HAMD-24 score after fourth ECT21.0 ± 4.422.4 ± 5.927.9 ± 7.7
HAMD-24 score after full ECT course12.3 ± 4.713.3 ± 5.117.0 ± 6.0
Baseline SDS score69.2 ± 7.465.8 ± 6.767.8 ± 6.0
SDS score after fourth ECT57.7 ± 7.956.1 ± 11.660.3 ± 5.3
SDS score after full ECT course49.7 ± 3.949.7 ± 5.754.4 ± 5.4
Baseline MoCA score24.8 ± 2.625.1 ± 2.924.9 ± 2.9
MoCA score after fourth ECT22.6 ± 2.123.5 ± 3.322.6 ± 3.1
MoCA score after full ECT course23.4 ± 1.724.4 ± 2.924.1 ± 2.5
Cardiorespiratory data
Baseline heart rate, bpm89.0 ± 9.887.0 ± 16.884.3 ± 19.3
Baseline systolic blood pressure, mmHg118.9 ± 14.1113.5 ± 14.0112.1 ± 11.3
Baseline diastolic blood pressure, mmHg74.4 ± 8.874.3 ± 11.370.0 ± 7.1
Baseline peripheral oxygen saturation, %96.8 ± 1.497.3 ± 1.297.3 ± 1.2
Table 2 Generalized linear mixed model examining effect of treatment, patient, and anesthesia factors on electroencephalography seizure parameters
Covariate/dependentEEG endpoint (s)
ASEI (μV2)
PSI (%)
Mid-ictal amplitude (μV)
Coherence (%)
Maximum heart rate, (bpm)
Recovery time (min)
Est
SE
P value
Est
SE
P value
Est
SE
P value
Est
SE
P value
Est
SE
P value
Est
SE
P value
Est
SE
P value
qCON0.3390.1600.036a34.150140.5260.8080.0570.0950.5530.5310.2320.023a0.0960.0620.1250.3310.1400.019a-0.0170.0390.664
qNOX-0.0110.1160.922-2.927116.1960.9800.1620.0790.042a0.2160.1910.2590.0010.0510.9880.0610.1140.5930.0220.0290.457
Age (years)-0.5970.2130.006a142.87994.2140.131-0.0790.0630.211-0.0640.1620.6930.0340.0460.4560.0910.1040.3840.0960.0460.039a
ECT number--0.000a--0.000a--0.024a--0.418--0.158--0.128--0.266
Charge, mC0.0680.6670.307-32.53930.4520.2870.0140.0200.4910.0320.0520.545-0.0070.0150.647-0.0240.0340.4830.0020.0150.888
Anesthetic-ECT time, interval (min)0.1570.0480.001a-17.20743.9830.6960.0720.0300.018a0.0410.0730.5750.0070.0200.7240.0740.0440.093-0.0010.0120.922
Table 3 The effect of anesthesia depth on electroencephalography seizure parameters: Findings of generalized linear mixed model analyses
Characteristics (dependent variable)
F value
P value
Maximum heart rate3.4600.034a
EEG endpoint3.3260.038a
ASEI0.2360.790
PSI7.0410.001a
Mid-ictal amplitude5.7170.004a
Coherence3.3640.037a
Maximum systolic blood pressure1.4900.228
Maximum diastolic blood pressure0.3750.688
Recovery time after treatment0.0950.909
Table 4 Adverse events reported by participants during anesthesia recovery period: Findings of Fisher’s precision probability test, n (%)
Adverse event
Group 11
Group 22
Group 33
χ²
P value
Headache5 (7.9)7 (10.8)4 (6.2)0.9260.629
Dizziness3 (4.8)6 (9.2)3 (4.6)1.4040.603
Nausea/vomiting3 (4.8)6 (9.2)4 (6.2)1.0410.677
Muscle soreness6 (9.5)5 (7.7)4 (6.2)0.5080.776
Delirium0 (0)0 (0)0 (0)--
Total11 (17.5)12 (18.5)10 (15.4)7.2920.274